Data Characteristics for this Category
siRNA nucleic acid drug data originates from various sources. These include public patent databases, clinical trial reports, academic papers, and internal research and development documents. Document update frequencies vary. Patent and clinical trial data may update quarterly or annually. Internal R&D data might change in real-time. Document structures also vary. Patents and clinical reports often contain structured summaries, sequence information, mechanisms of action, pharmacokinetic data, and toxicology results. Sequence information typically appears in FASTA format, accompanied by descriptions of modification sites, target genes, and design principles. Units commonly used include nM or µM for concentration, mg/kg for dosage, and hours or days for action time.
Constraints Imposed by these Characteristics on Workflow Orchestration
The diversity and update frequency of siRNA nucleic acid drug data demand robust workflows. Varying document structures mean workflows must handle semi-structured and unstructured data. This includes extracting key sequence or target information from free text. Inconsistent update frequencies require workflows to support incremental updates and version management, ensuring knowledge base timeliness. Furthermore, the specificity of sequence data requires workflows to correctly identify and parse nucleic acid sequences. Workflows must also associate these sequences with relevant metadata, such as modifications and targets. Accurate identification of units and numerical values helps prevent errors in dosage calculations or efficacy assessments.
Configuration Settings
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Chunk size | 500–800 characters | Balances semantic completeness and vector recall efficiency; avoids noise from overly long paragraphs. |
Recall count | 10 entries | Covers various potentially relevant information, enriching context. |
Similarity threshold | Calibrated by empirical testing | Balances recall rate and accuracy based on specific data distribution and application scenarios. |
Rerank result count | 3 entries | Selects the most relevant information, improving the precision of the final output. |
maxContext | 4096 tokens | Accommodates mainstream model input limits, ensuring context completeness. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Handles parsing of large patent or clinical report files, preventing timeout failures. |
Three Common Mistakes
- Global variables appear as
undefinedor null when referenced in a workflow. This happens due to incorrect variable scope configuration or if the assignment node executes after the reference node. - Workflows frequently encounter
HTTP 504 Gateway Timeouterrors during execution. This commonly occurs when parsing large or complex documents ifPARSE_FILE_TIMEOUT_SECONDSis set too low. - Query results lack critical sequence or dosage information. This typically results from incomplete extraction rules for specific fields in the knowledge base configuration, failing to accurately identify and extract these unique biomedical data points.
How to Verify Configuration
- Upload a typical siRNA nucleic acid drug patent document. Observe if the parsing results accurately extract nucleic acid sequences, target genes, and key dosage data.
- Execute a workflow containing multiple data sources. Check if data transfer at each node meets expectations, especially context completeness when referencing across knowledge bases.
- Simulate user queries. Ask questions targeting different sequences, targets, or disease names. Evaluate the accuracy and relevance of the returned results. Adjust
Similarity thresholdbased on this evaluation.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.